DRUG ADDICTION. IS IT A DISEASE OR IS TT BASED ON CHOICE? A REVIEW OF GENE HEYMAN'S ADDICTION: A DISORDER OF CHOICE

被引:7
|
作者
Branch, Marc N. [1 ]
机构
[1] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA
关键词
drug addiction; chronic disease; operant choice; framing; NATIONAL EPIDEMIOLOGIC SURVEY; DSM-IV ALCOHOL; UNITED-STATES; COMORBIDITY; ABUSE;
D O I
10.1901/jeab.2011.95-263
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
In Addiction: A disorder of choice, Gene Heyman surveys a broad array of evidence historical, anthropological, survey, clinical, and laboratory-based to build an argument about the role of basic choice processes in the phenomena that comprise drug addiction. He makes a compelling, multifaceted argument that conceptualizing drug addiction as a chronic disease (like schizophrenia or diabetes) is both misleading and erroneous. In developing his argument, he points out that the best survey data available indicate that most drug addicts quit their addiction, a fact inconsistent with a chronic-disease model. He illustrates how basic, normal choice processes can lead to addiction, arguing that people do not choose to be addicts, but that normal choice dynamics can lead them to that condition. He points to a variety, of factors that keep most from becoming addicted, with a focus on the role of choice governed by choice-by-choice contingencies versus choice governed by the outcome of sequences of choices, a difference in an under-described activity called framing. His view is consistent with the most effective treatments currently available, and provides a basis for continued basic research on choice as well as research on treatment and prevention.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 50 条
  • [41] Direct and indirect freedom in addiction: Folk free will and blame judgments are sensitive to the choice history of drug users
    Taylor, Matthew
    Maranges, Heather M.
    Chen, Susan K.
    Vonasch, Andrew J.
    CONSCIOUSNESS AND COGNITION, 2021, 94
  • [42] Dopamine D2/3 Receptor Availability Associated with Simulated Drug Choice in Methamphetamine Addiction
    Moeller, Scott
    Robertson, Chelsea
    Okita, Kyoji
    Ballard, Michael
    Konova, Anna
    Goldstein, Rita
    Mandelkern, Mark
    London, Edythe
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S242 - S243
  • [43] Levodopa Addiction and Factitious Disorder in a Patient With Idiopathic Parkinson's Disease
    Zaharna, Mia
    Pandya, Mayur
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 22 (03) : E11 - E12
  • [44] Adding a choice-based program for tobacco smoking to an abstinence-based addiction treatment program
    Bernstein, SM
    Stoduto, G
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1999, 17 (1-2) : 167 - 173
  • [45] Choice and Partnership Approach to community mental health and addiction services: a realist-informed scoping review
    Campbell, Leslie Anne
    Clark, Sharon E.
    Chorney, Jill
    Emberly, Debbie
    MacDonald, Julie
    MacKenzie, Adrian
    Warner, Grace
    Wozney, Lori
    BMJ OPEN, 2022, 12 (10):
  • [46] Factitious disorder mimicking addiction to levodopa in a patient with advanced Parkinson's disease
    Teixeira-Jr, AL
    Cardoso, F
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (2A) : 324 - 326
  • [47] CRAVING, EXPERIENCE, CONSCIOUSNESS, AND TEMPORALITY IN DRUG ADDICTION. A CLINICAL REFLECTION FROM HUSSERL'S PHENOMENOLOGY, VARELA'S APPROACH AND MATURANA'S BIOLOGY OF COGNITION
    Romero Romero, Juan Carlos
    Perez Zapata, Daniel
    LIMITE-REVISTA DE FILOSOFIA Y PSICOLOGIA, 2010, 5 (21): : 95 - 116
  • [48] Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development
    Negus, S. Stevens
    Banks, Matthew L.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2018, 164 : 32 - 39
  • [49] The choice of first symptomatic drug treatment in Parkinson's disease
    Keranen, T.
    Virta, L. J.
    MOVEMENT DISORDERS, 2015, 30 : S96 - S96
  • [50] Drug choice in preventing postoperative Crohn's disease - Reply
    McLeod, RS
    GASTROENTEROLOGY, 1996, 110 (02) : 652 - 653